다음과 같은 기능을 한번의 로그인으로 사용 할 수 있습니다.
NTIS 바로가기
Clinical neuropharmacology, v.28 no.5, 2005년, pp.249 - 251
Kim, Sung-Wan (From the *Department of Psychiatry, Chonnam National University Medical School) , Shin, Il-Seon (and the †Clinical Trial Center and Depression Clinical Research Center, Chonnam National University Hospital, Kwangju, Korea.) , Kim, Jae-Min , Lim, So-Yeon , Yang, Su-Jin , Yoon, Jin-Sang
Selective serotonin reuptake inhibitors (SSRIs) have been recognized as the treatment of choice for pathological laughing and crying (PLC), which is a common, distressing condition that follows stroke. There have been few reports about other treatment options for PLC. Here, the authors report rapid responses to mirtazapine in two patients with poststroke PLC who failed to respond to SSRIs or bupropion. In the first case, a 63-year-old woman with severe long-standing crying spells that had persisted for 3 months responded well to low-dose mirtazapine within a few days; she could not tolerate citalopram or sertraline. In the second case, both the laughing and crying spells of a 64-year-old woman were improved within a few days of mirtazapine administration, after they had not responded to bupropion. This is one of the first reports to suggest that mirtazapine may be an alternative to SSRIs for treating poststroke PLC.
House BMJ 1989 10.1136/bmj.298.6679.991 198 991
Kim Neurology 2000 10.1212/WNL.54.9.1805 54 1805
Parvizi Brain 2001 10.1093/brain/124.9.1708 124 1708
Kim J Neurol 2002 10.1007/s00415-002-0714-4 249 805
Anderson Stroke 1994 10.1161/01.STR.25.5.1050 25 1050
Murai Psychiatry Res 2003 10.1016/S0925-4927(03)00065-9 123 207
Andersen Lancet 1993 10.1016/0140-6736(93)92696-Q 342 837
Muller Brain Inj 1999 10.1080/026990599121197 13 805
Burns Int J Geriatr Psychiatry 1999 10.1002/(SICI)1099-1166(199908)14:8<681::AID-GPS49>3.0.CO;2-Z 14 681
Brown Acta Psych Scand 1998 10.1111/j.1600-0447.1998.tb10119.x 98 455
Schiffer N Engl J Med 1985 10.1056/NEJM198506063122303 312 1480
Robinson Am J Psychol 1993 10.1176/ajp.150.2.286 150 286
Ramasubbu Clin Neuropharmacol 2003 10.1097/00002826-200309000-00006 26 233
Smith J Clin Psychiatry 2003 10.4088/JCP.v64n0618a 64 731
Chouinard Can J Neurol Sci 1980 7 233
Hamilton J Neurol Neurosurg Psychiatry 1960 10.1136/jnnp.23.1.56 23 56
Schillevoort Int Clin Psychopharmacol 2002 10.1097/00004850-200203000-00006 17 75
Gordon Parkinsonism Relat Disord 2002 10.1016/S1353-8020(02)00011-1 9 125
Blier J Clin Psychiatry 2001 10.4088/JCP.v62n0104 62 12
Udaka Arch Neurol 1984 10.1001/archneur.1984.04050210093023 41 1095
Calvert J Neurol Neurosurg Psychiatry 1998 10.1136/jnnp.65.6.928 65 928
Copyright KISTI. All Rights Reserved.
※ AI-Helper는 부적절한 답변을 할 수 있습니다.